Effect of Sitagliptin in Impaired Glucose Tolerance
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety and efficacy of sitagliptin 100 mg every
day (q.d.) in improving hyperglycemia and endothelial dysfunction in subjects with impaired
glucose tolerance.